The Monoclonal Antibodies Strike Back: New Data on Their Use in COVID-19
Listen to Sharon R. Lewin, AO, FRACP, PhD, FAHMS, and Arthur Kim, MD, discuss exciting new data on the use of monoclonal antibodies for the treatment and prevention of COVID-19.
Decera Clinical Education Infectious Disease Podcast
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this podcast episode, Sharon R. Lewin, AO, FRACP, PhD, FAHMS, and Arthur Kim, MD, discuss data on the potential use of monoclonal antibodies (mAb) for the prevention and treatment of COVID-19, including:
- Rationale for use of mAb
- Potential for resistance to mAb
- Single vs combination therapy with mAb
- Challenges in implementation of mAb as treatment or prevention
- Bamlanivimab
- Sotrovimab
- Casirivimab plus imdevimab
Link to full program, including downloadable slidesets: https://bit.ly/3zVTwYW
Presenters:
Sharon R. Lewin, AO, FRACP, PhD, FAHMS
Director, The Peter Doherty Institute for Infection and Immunity
Professor of Infectious Diseases
Faculty Medicine Dentistry and Health Sciences
University of Melbourne and Royal Melbourne Hospital
Consultant Infectious Diseases Physician
Department of Infectious Diseases
Royal Melbourne Hospital and Alfred Hospital
Melbourne, Australia
Arthur Kim, MD
Associate Professor
Department of Medicine
Harvard Medical School
Director, Viral Hepatitis Clinic
Division of Infectious Diseases
Massachusetts General Hospital
Boston, Massachusetts
Sharon R. Lewin, AO, FRACP, PhD, FAHMS, has disclosed that she has received consulting fees from AbbVie, Gilead Sciences, and ViiV Healthcare; funds for research support from Leidos; and other financial or material support from Gilead Sciences, Merck, and ViiV Healthcare.
Arthur Kim, MD, has disclosed that he has served on the drug and safety monitoring board for Kintor.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.